Decrease in Autoantibody Titres During Long-term Treatment of Scleroderma with Rituximab: a Promising Surveillance Marker of Therapy?
Overview
Overview
Journal
Scand J Rheumatol
Publisher
Informa Healthcare
Specialty
Rheumatology
Date
2015 Sep 18
PMID
26376839
Citations
1
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Anti-topoisomerase 1 Antibody Level Changes after B Cell Depletion Therapy in Systemic Sclerosis.
Ananyeva L, Garzanova L, Koneva O, Starovoytova M, Desinova O, Ovsyannikova O Dokl Biochem Biophys. 2023; 511(1):212-218.
PMID: 37833608 PMC: 10739332. DOI: 10.1134/S1607672923700266.